DaVita is a medical care facilities business based in the US. DaVita stocks (DVA.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $101.66 – a decrease of 5.96% over the previous week. DaVita employs 67,000 staff and has a trailing 12-month revenue of around $11.6 billion.
How to buy shares in DaVita
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – DVA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in DaVita?
- Has coronavirus impacted DaVita shares?
- DaVita shares summary
- Compare share dealing platforms
- Is DaVita stock a buy or sell?
- DaVita performance over time
- Is DaVita suitable for ethical investing?
- Are DaVita shares over-valued?
- DaVita's financials
- How volatile are DaVita shares?
- Does DaVita pay a dividend?
- Have DaVita shares ever split?
- Other common questions
DaVita stock price (NYSE:DVA)Use our graph to track the performance of DVA stocks over time.
DaVita shares at a glance
|Latest market close||$109.39|
|52-week range||$94.38 - $136.48|
|50-day moving average||$106.73|
|200-day moving average||$116.93|
|Wall St. target price||$127.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$8.56|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy DaVita stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
DaVita price performance over time
|1 week (2022-01-13)||-5.12%|
|1 month (2021-12-17)||4.31%|
|3 months (2021-10-17)||N/A|
|6 months (2021-07-21)||-8.92%|
|1 year (2021-01-21)||-8.32%|
|2 years (2020-01-21)||36.91%|
|3 years (2019-01-18)||90.67%|
|5 years (2017-01-20)||73.58%|
Is DaVita under- or over-valued?
Valuing DaVita stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of DaVita's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
DaVita's P/E ratio
DaVita's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, DaVita shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
DaVita's PEG ratio
DaVita's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.9728. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into DaVita's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
DaVita's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.4 billion.
The EBITDA is a measure of a DaVita's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$11.6 billion|
|Operating margin TTM||15.26%|
|Gross profit TTM||$3.6 billion|
|Return on assets TTM||6.37%|
|Return on equity TTM||41.87%|
|Market capitalisation||$11.9 billion|
TTM: trailing 12 months
DaVita's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like DaVita.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
DaVita's total ESG risk score
Total ESG risk: 20.07
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and DaVita's overall score of 20.07 (as at 01/01/2019) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like DaVita is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
DaVita's environmental score
Environmental score: 2.6/100
DaVita's environmental score of 2.6 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that DaVita is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
DaVita's social score
Social score: 10.68/100
DaVita's social score of 10.68 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that DaVita is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
DaVita's governance score
Governance score: 7.8/100
DaVita's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that DaVita is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
DaVita's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. DaVita scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that DaVita has, for the most part, managed to keep its nose clean.
DaVita share dividends
We're not expecting DaVita to pay a dividend over the next 12 months.
Have DaVita's shares ever split?
DaVita's shares were split on a 2:1 basis on 9 September 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your DaVita shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for DaVita shares which in turn could have impacted DaVita's share price.
DaVita share price volatility
Over the last 12 months, DaVita's shares have ranged in value from as little as $94.38 up to $136.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while DaVita's is 1.2377. This would suggest that DaVita's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States.
Stocks similar to DaVita
DaVita in the news
DaVita : How to get support during inclement winter weather
Sippican Capital Advisors Buys Coterra Energy Inc, DaVita Inc, Physicians Realty Trust, Sells ...
Warren Buffett’s 5 Worst Performing Stock Picks From 2021
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.